Detalles de la búsqueda
1.
Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers.
Br J Cancer;
126(1): 10-23, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400801
2.
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells.
Br J Cancer;
127(4): 649-660, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35597867
3.
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients.
Liver Transpl;
28(1): 98-112, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081828
4.
The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer.
Liver Int;
41(1): 206-219, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33084231
5.
HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis.
Br J Cancer;
122(8): 1211-1218, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071413
6.
Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis.
Br J Cancer;
123(2): 196-206, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32418992
7.
Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
Carcinogenesis;
40(1): 145-154, 2019 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30289434
8.
Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
Carcinogenesis;
40(1): 155-163, 2019 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30325409
9.
GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
Int J Cancer;
145(4): 1111-1124, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30719701
10.
Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
J Hepatol;
71(4): 753-762, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195061
11.
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Gastroenterology;
153(4): 1107-1119.e10, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28648905
12.
Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury.
Gastroenterology;
153(4): 1133-1147, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28716722
13.
Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation.
Clin Transplant;
32(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193362
14.
Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
J Surg Oncol;
118(1): 68-76, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29878369
15.
Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.
Int J Cancer;
141(3): 572-582, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28470686
16.
Cytomegalovirus-Induced Expression of CD244 after Liver Transplantation Is Associated with CD8+ T Cell Hyporesponsiveness to Alloantigen.
J Immunol;
195(4): 1838-48, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26170387
17.
Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
J Hepatol;
64(6): 1274-82, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26941095
18.
Differential Sensitivities of Fast- and Slow-Cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid.
Mol Med;
21(1): 792-802, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467706
19.
Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function.
Liver Int;
36(6): 883-92, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26344705
20.
Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production.
J Immunol;
192(12): 5625-34, 2014 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24808368